CD8+T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors

Overview of attention for article published in Molecular Cancer, February 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 40 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

T cells expressing membrane-anchored IL-12 for the treatment of cancer

Grant US-11421010-B2

United States of America

T CELLS EXPRESSING MEMBRANE-ANCHORED IL-12 FOR THE TREATMENT OF CANCER

Application EP-3523323-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.